CD44 and neoplasm: The range of CD44 expression in primary SCCOHT tumors was more dynamic than with Claudin-4, shown by select tumor cores that moderately expressed CD44 (range of CD44/DAPI in SCCOHT = 0.22–31.9%) (Figure 3h).